Medicines safety monitoring is a continuous process that begins with pre-marketing clinical trials and continues with post-marketing studies to fill any gaps in knowledge. With Marianne Lunzer from AGES and Sanja Prpić from HALMED, we review the pros and cons of various study types and the importance of testing medicines on diverse populations. Tune in to f ... Show More
Nov 21
#41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén
<p>Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities but also increased the stakes. How do we use them without losing tru ... Show More
29m 9s
Oct 17
#40 How to use artificial intelligence in pharmacovigilance, part 1 – Niklas Norén
<p>Far from a future add-on, artificial intelligence is already embedded in the cycle of drug safety, from case processing to signal detection. Versatile generative AI models have raised the bar of possibilities, but they have also increased the stakes. How do we use them without ... Show More
29m 1s
Jun 2024
Trial of the Week: PROWESS-SHOCK
Trial of the Week: PROWESS-SHOCKSpecial Guest: Paul Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS @paulszumita 03:30 – Background studies/Setting the scene30:25 – PROWESS-SHOCK discussion/Where are we now Paul Szumita joins to highlight a June Trial of the Week “Drotrecogin alfa (act ... Show More
1 h
Sep 26
Sep 26 2025 This Week in Cardiology
A bold trial in valvular heart disease, a CV prevention trial whose message is humility, VTE dogma challenged, more news on oral GLP-1 agonists, and a few public service announcements are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for ... Show More
22m 50s
Feb 2025
PTJ Author Interview: Randomized Clinical Trials and Real-World Practice
<p>In this episode of the PTJ Podcast, Editor-in-Chief Steven George, PT, PhD, FAPTA, talks with Alexander Garbin, PT, DPT, PhD, and Jennifer Stevens-Lapsley, PT, PhD, FAPTA, about their recently published companion papers, which evaluated the effectiveness of a progressive multi ... Show More
24m 12s
Jan 2024
How Can We Reduce Unnecessary Lab Testing?
Laboratory tests provide doctors with crucial information for diagnosis, monitoring disease progression, evaluating organ function, assessing risk factors for diseases and more. Laboratory testing can be reassuring, however, it is often deemed unnecessary. In this short episode r ... Show More
15m 15s
Feb 2025
The Truth About Nutrition: How You Can Take a Science-Based Approach | Bradley Johnston PhD
<p>Misinformation in nutrition is rampant. From demonizing red meat to hyping plant-based diets, conflicting advice has left many people confused about what’s truly evidence-based. In this episode, I am joined by Dr. Bradley Johnston<strong>, </strong>an expert in evidence-based ... Show More
1h 30m
Jul 2021
COVID-19: Vaccine immunogenicity, interleukin-6 inhibitors, mucormycosis
Kieran Walsh, clinical director at BMJ, asks editors from BMJ Learning and BMJ Best Practice to summarise the latest clinical guidance related to Covid-19. Abigail Davis, GP and section editor, covers the latest evidence around vaccine immunogenicity in different immunosuppressed ... Show More
12m 6s